Career Seminars

A new seminar series at the IRIM has been launched in 2019, aiming at providing experience and feedbacks from people with successful and interesting careers outside academia, and who previously did a PhD and, possibly, one postdoc (or several postdocs!). The 'Career outside academia’ seminars are held for PhD students and postdocs, in an informal and relaxed context and any type of questions/discussions are welcome.

Please contact the organizers if you have any questions: Caroline Goujon, Boris Bonaventure or Nuria Andrés (IGMM) who's recently joined the organizer team.

Future seminars:

 


Bénédicte Fauvel, Chief Operating Officer, MedXeCell. 15th of September 2021, 12h30, salle Marcel Dorée & on Zoom.

Bénédicte's minibio : Bénédicte obtained her PhD in biology from Montpellier University in 2004. During her thesis at the CPBS (Centre d'études d'agents Pathogènes et Biotechnologies pour la Santé, now IRIM), she had studied HIV-1 and HTLV-I replication, with a focus on the late phases of the virus replication cycle. In 2005, Bénédicte had joined Sanofi as postdoc for 18 months, with a project aiming to develop preclinical tests for the screening or validation of new molecules. In 2007, she participated in the creation of a start-up in Montpellier (OriBase Pharma), with the goal of developing new therapies (chemical compounds and monoclonal antibodies) in oncology. She spent 9 years in this company, first as a R&D project leader, then as the Head of preclinical pharmacology, and finally as the joint director, Head of the preclinical development. In 2016, she joined the "société d’accélération de transfert de technologies", SATT AxLR, as Project Leader for the Health and Biotechnology Axis, with the goals of detecting, investing, following, guiding and transfering innovative research projects. In 2021, she joined the company MedXCell as the COO (Chief Operating Officer) in order to supervize and accelerate the company development.

-- see flyer 

 

Past seminars:


Virginie Courtois, manager of the Molecular Biology Unit, Research department, Sanofi Pasteur (France). Mercredi 28 Juillet, 12h30, via Zoom. This seminar was held in French.

Virginie's minibiography: Virginie started doing research as a technician during holiday periods in an INSERM lab located in Clermont-Ferrand. She then obtained a BsC and Master in Molecular and cellular biology from Claude Bernard Lyon I university and did a PhD in Molecular and cellular biology at the Ecole Normale Supérieure de Lyon. Her PhD research was on the study and characterization of a gene essential for mouse brain development; she obtained her PhD in October 2002. She then worked for a start-up based in Lyon and with the national reference center for cystic fibrosis (hôpital Henri Mondor, Créteil) to develop a diagnostic test using DNA arrays and surface chemistry. In 2006, she joined Merial company (today Bohringer Ingenheim), specialized in animal health, as a molecular biologist in charge of DNA vaccine development. At the end of 2006, she joined the Vaccine Unit of Sanofi Pasteur, as the Research Unit Manager for recombinant antigen production. Since then, she's held several Scientific Manager positions in the Research department at Sanofi Pasteur, covering Molecular Biology, antigen production using different expression systems, as well as transcriptmics/proteomics.

See flyer:

 

 

Benjamin Muller, IDEXX, R&D manager. Wednesday the 7th of July 2021. 12h30 via Zoom.

Benjamin Muller's minibio: After an Engineer diploma in biotechnology at ENSTBB in Bordeaux in 2009, I worked as an study engineer in CNRS, at IGMBC in Illkirch-Graffenstaden. I was in charge of proteins purification in the lab. Then I had the opportunity to do a PhD in collaboration between UMR5235 (Michel Vidal's team) and Ciloa, a start-up working on exosomes in Montpellier, where I worked on the development of monoclonal antibodies using exosomes. After my PhD, I joined IDEXX (veterinary company producing diagnostic kits) were I started in R&D as a project manager in charge of the development of new diagnostic kits and became R&D manager on Montpellier's in 2017. In 2018, I joined the Production team and became Manager of the Technical Manufacturing Service, where  we produce and validate the antigens and antibodies used in the diagnostic kits.

See flyer:
 

Darja Pollpeter, Scenic Biotech (The Netherlands). Wednesday the 16th of Hune, 12h30, via Zoom.

Darja's minibio: Darja obtained a degree in biochemistry at the University of Leipzig, Germany, before she started her PhD at Northwestern University in Evanston, USA in 2005. As a PhD student she studied the innate immune responses and viral sensing to infections with paramyxoviruses, such as measles or mumps. In 2011, Darja moved to King's College London for a postdoc with Michael Malim working in host restriction to HIV infection. Afterwards she joined the Biotech start-up company Scenic Biotech, which was founded in 2017 and located in Amsterdam Netherlands. At Scenic she is currently involved in both R&D to identify genetic modifiers for rare diseases as well as drug development for immuno oncology targets. 

See flyer:

 

Tuesday the 10th of March 2020, 18h, Salle de Séminaire de l'IGMM. Pascale Joseph, Intellectual Property Manager, Deinove.

Pascale Joseph's minibio: Pascale obtained her PhD. in Microbiology and Biotechnology in 2002 from University of Mediterranean (LCB-CNRS, Marseille). Her work allowed the discovery of very well conserved genes clusters in Gram positive bacteria and their role in antibiotic resistance. Then, she hold two successive post-doctoral positions respectively, at Tufts University School of Medicine (Boston-Massachusetts, USA, 2002-2005) and at Infectiology Research Institute of Montpellier (IRIM, Ex-CPBS, 2005-2007) where she continued to work in the field of Bacteriology and Drug Discovery. After 10 years in academia, she joined in 2008 the French Biotech Start-up, DEINOVE, initially as R&D Project Manager on Bio-based Ethanol Production Process using bacteria. Then, in 2012, she became the Intellectual Property Manager and Legal of the Company which now focuses on Drug Discovery, Antibiotic Resistance and Development of Innovative Bio-based active Ingredients for Cosmetics and Nutrition. 

 

Thursday the 9th of January, 11h30, Salle de Séminaire de l'IGMM. The speaker was Victor Racine, founder of Quantacell. This seminar was held in French.

Victor Racine's minibio: After an Engineering diploma in informatics and a DEA (Master) in Biophysics, Victor did his PhD in cell imaging quantification at the Institut Curie on vesicular trafficking (2003-2006). He then did a postdoc at Singapore where he performed High Content Screenings and worked on quantitative histology at the IMCB (Institute of Molecular and Cell Biology 2007-2009). With the aim of discovering the research in industry, he then worked in 2 biotechs in Bordeaux (2010-2013). In 2014 he has created the QuantaCell company in Bordeaux and later on in Montpellier, which offers imaging analysis service and AI for biomedical imaging. 

-- see flyer

Friday the 29th of November, 13h, Salle de Séminaire de l'IGMM. The speaker was Julie Bayle, Scientific communication manager at Royal Canin. This seminar was held in English.

After a Master and PhD in immunology in Marseille, Julie did a 2-year postdoc at Boston university in dermatology. After that, she spent 5 years as project manager (preclinical and clinical drug development) in a start up in Montpellier (Medesis Pharma). She then joined the MARS group in 2012 as a researcher in the R&D team of Royal Canin. Since July 2018, Julie has been Scientific communication manager at Royal Canin and is in charge of 13 emerging markets.

-- see flyer

Wednesday the 2nd of October, 9h15 Salle Marcel Dorée. The speaker was Benoit Giquel, Outreach Scientist Europe for Addgene. This seminar was held in English.

Benoit Giquel's minibio: After a Master in Developmental Physiology and Functional Differentiation at the University of Paris 7, Benoit completed a PhD in Developmental Biology at the Cochin Institute on the role of HLA-B27 in the onset of spondyloarthropathies. He then pursued his career with three post-docs in Immunology laboratories. The first took place in Paris, at the St Vincent de Paul Hospital, where he worked on the role of NKT cells in the progression of the X-linked adrenoleukodystrophy. He then moved to the UK, at the King’s College London, to study first the use of TLR ligands in anti-tumour immunotherapy and then the role of the MPEG1 molecule in the antibody-dependent cell-mediated cytotoxicity. No longer attracted by the sirens of research, he later joined Addgene, in 2014, as an Outreach Scientist for Europe, with the mission of raising awareness about Addgene on the old continent. Since 2018, he has been the manager of the Addgene Europe office in London.

-- see flyer

Monday the 16th of September, 12h, Salle de séminaire de l'IGMM. The speaker was Mariella Lomma, Medical Advisor France at Biomérieux. This seminar was held in French.

Mariella Lomma's minibio: After a Master in Biotechnology at Bologna university (Italy), Mariella did her PhD in microbiology at the Pasteur institute, and a postdoc at Imperial College London (UK). In 2013, she leaves basic research and became Scientific Editor at Nîmes' university hospital (CHU). After 3 years in this position, she joined the biomedical industry and first became Medical Science Liaison at Basilea Pharmaceutica, and later Clinical Development Manager at Accelerate Diagnostics. In May 2019, she has joined BioMérieux as a Medical Advisor.

-- see flyer

 

Thursday the 13th of June 2019, 17h45, Salle de séminaire de l'IGMM. The speaker was Hélène Bauby, Market Development Manager and NGS specialist at Qiagen.

-- see flyer

Hélène Bauby's minibio : after a Master in microbiology at the Pasteur Institute, Hélène did her PhD at the INRA on Arabidopsis thaliana's phloem development. She then studied the interactions between HIV-1 and primary cells during a first postdoc at Cochin Institute in Paris and a second postdoc at King's College London. After 13 years in academia, she joined Qiagen (provider of molecular biology kits), initially as a rep. In 2016, she has become Market Development Manager, in charge of the development of reagents for NGS for Qiagen in France and Belgium.

Wednesday the 15th of May 2019, 11h, Salle de séminaire de l’IGMM. The speaker was Philippe Villain-Guillot, Nosopharm’s CEO.

Philippe Villain-Guillot's minibio : After an Engineer diploma in chemistry from ENSCM, Philippe went to the UK in 2003 and worked for Evotec as a medicinal chemist. He started his PhD thesis in 2004 in chemistry, in the antibiotics field, under the supervision of Jean-Paul Leonetti at Montpellier university. After his PhD, Philippe co-founded in 2009 the Nosopharm biotech company, specialized in research and development of new antibacterial molecules. He's been Nosopharm's CEO since then, and is more specifically in charge of all aspects concerning funding, business development and intellectual property.

-- see flyer

 

 Thursday the 11th of April, 12h30, Salle de séminaire de l'IGMM. The speaker was Michaël Girardot, who is senior data scientist at CGI, here in Castelnau-le-Lez.

-- see flyer

Michael Girardot’s minibio: Michael holds a Ph.D. in Genetics and specializations in epigenomics and bioinformatics. He did his thesis at the INRA (Limoges). He then moved to Brussels for a first postdoc at the Ludwig Institute for Cancer Research and, after that, he came to Montpellier for a second postdoc at the IGMM. After 15 years of research experience in academic research, he performed vocational retraining as a Data Scientist. In 2016, he joined CGI as a senior consultant in Big Data and Data Science. CGI is one of the largest IT and business process services providers in the world.

Thursday the 14th of March, 9h, Salle Marcel Dorée. The speaker was Nicolas Reymond, who is project manager at Eurobiomed, here in Montpellier. After 2 postdocs, Nicolas obtained an MBA and then joined the Eurobiomed cluster.

-- see flyer

Nicolas Reymond’s minibio: Nicolas holds a PhD in immunology and, after 15 years working as a project manager in academic labs (including many years abroad, in the UK, the USA and Canada), Nicolas did a Master's in Management and Business Administration. He then held marketing positions at Histalim, having operational marketing responsibilities and strategic responsibilities. Nicolas joined the Eurobiomed Cluster in 2016. He is in charge of the organization and development of the center's activities in the Montpellier branch. With his strong dual scientific and managerial expertise, he supports the development of companies in Biology/ Health in the region and promotes interactions between different ecosystem actors.

Monday the 11th of January, 13h30, Salle de séminaire de l’IGMM. The speaker was Cécile Herbreteau, who is the head of Research and Development of the pharmaceutical company Fab’entech, based in Lyon.

-- see flyer

Cécile Herbreteau’s minibio: After a master in molecular and cellular biology at the Ecole Normale Supérieure (ENS) of Lyon, Cécile obtained a PhD in molecular virology in 2006. She then did a postdoc at the Centre Léon Bérard (Lyon). In 2009, she became a project manager at Idealp Pharma, which was specialized in Drug Discovery. In 2010, she joined the pharmaceutical company Fab’entech.


     
   

   

Enregistrer

Enregistrer

Enregistrer

Enregistrer

Enregistrer

IRIM
Institut de Recherche en Infectiologie de Montpellier
UMR 9004 - CNRS / UM
1919 route de Mende - 34293 Montpellier cedex 5
FRANCE

 

Enregistrer

Enregistrer

Enregistrer

Enregistrer

Enregistrer

Enregistrer